Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03099070 · ClinicalTrials.gov registry record · NA

Acute Stress Response in Migraine Sufferers

A NA study, sponsored by Massachusetts General Hospital.

Terminated
Registry status
NA
Development phase
90
Enrollment target

NCT03099070: Clinical Trial NA study, sponsored by Massachusetts General Hospital.

NCT03099070 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03099070, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.

TERMINATED
Registry status
NA
Development phase
90 participants
Enrollment target

Study Summary

This study will examine the influence of stress and fasting on headache activity. Participants will receive both a control and stress session and be randomized to either fasting or not fasting for the visits.

Primary Outcome

The presence of a headache attack that is \>= 4/10 on a 0 to 10 scale or a headache attack that requires the use of abortive/analgesic medication

Interventions

  • OTHER Fasting
  • BEHAVIORAL Stress

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2017-03-08
Est. Completion 2020-08-15
Phase NA
Massachusetts General Hospital

2,032 total trials

Why NCT03099070 stopped before completion

NCT03099070 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Fasting is the first listed.

NCT03099070 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03099070 about?

NCT03099070 is a clinical study titled "Acute Stress Response in Migraine Sufferers". This study will examine the influence of stress and fasting on headache activity. Participants will receive both a control and stress session and be randomized to either fasting or not fasting for the visits.

What is the current status of trial NCT03099070?

This trial is currently terminated. It is a NA study. The enrollment target is 90 participants. The study started on 2017-03-08. Estimated completion is 2020-08-15.

What interventions are being tested in trial NCT03099070?

The interventions under investigation include: Fasting (OTHER), Stress (BEHAVIORAL).

Who is sponsoring clinical trial NCT03099070?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03099070's enrollment target sits among peer trials

90 941st of 2000 higher than 1,029 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03099070, the US trial registry maintained by the National Library of Medicine. NCT03099070 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.